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TRP channelAtrial ﬁbrosis is one of the fundamental mechanisms for the
pathogenesis of atrial ﬁbrillation (AF), but the underlying electro-
physiological changes involved are not completely understood.
Aging, neurohumoral activation, and chronic atrial stretch due to
structural heart disease activate various signaling pathways that
lead to cellular hypertrophy, ﬁbroblast proliferation, and complex
alterations of the extracellular matrix (ECM), such as tissue
ﬁbrosis; these may lead to disruption of the electrical side-to-
side junctions between muscle bundles [1], resulting in electrical
dissociation. Cardiomyocytes and cardiac ﬁbroblasts are 2 major
myocardial cell types, which constitute o50% and 40–60% of the
total cell population, respectively [2,3]. In normal adult hearts,
quiescent ﬁbroblasts substantially outnumber myocytes, and in
response to hemodynamic stress or injury, these ﬁbroblasts
differentiate into myoﬁbroblasts that proliferate, secrete collagen,
and synthesize new proteins such as α-smooth muscle actin
(α-SMA), stretch-sensitive ion channels, and connexins [4].
Fibroblasts have arrhythmogenic properties such as those
involved in blocking impulse propagation and differentiation into
myoﬁbroblasts, which have contractility, have electrical connectivity
and stimulate electrical impulse. The alteration of ﬁbroblast-induced
electrical impulses depends on the number of ﬁbroblasts: small
numbers of ﬁbroblasts lead to slow impulse conduction whereas
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electrical impulse propagation alteration to myoﬁbroblasts, which is
a key factor of the proarrhythmic mechanism. During embryonic
development, mesenchymal cells migrate from the proepicardium to
the epicardium, where they differentiate into epicardial-derived cells,
which differentiate into ﬁbroblast or myoﬁbroblast phenotypes.
Although phenotypically most of these epicardial-derived cells
differentiate into ﬁbroblasts, these cells can differentiate into myoﬁ-
broblasts in response to injury or stress [6,7]. The incidence of
ﬁbrosis increases after ﬁbroblasts are transformed to activated
ﬁbroblasts or myoﬁbroblasts [5–8]. Myoﬁbroblasts have contractile
proteins and α-smooth muscle actin (SMA), which is a smooth
muscle cell marker with enhanced migratory and proliferative
properties [2]. Transforming growth factor-β (TGF-β) has shown to
induce differentiation of ﬁbroblasts to myoﬁbroblasts in cultures [8].
Fibroblasts also differentiated to myoﬁbroblasts in connexin-
abundant cultures, especially in cultures mimicking the post-
myocardial infarction (MI) state [4,9]. Askar et al. [10] reported that
cardiomyocyte hypertrophy and ﬁbrosis induced by myoﬁbroblast
proliferation have similar arrhythmogenicity. This study reported
that prolonged action potential durations (APDs) and early after
depolarization (EAD)-triggered activity observed in cultured hyper-
trophic and ﬁbrotic tissue led to a high incidence of spontaneous re-
entrant arrhythmias or focal arrhythmias [10]. In addition, they found
that high myoﬁbroblast contents in cardiac cultures were associated
with depolarized membrane potentials in cardiomyocytes, prolonged
APD80, and increased incidence of EADs that lead to arrhythmias [10].
Arrhythmogenicity may also be induced by paracrine factors
secreted by ﬁbroblasts. The paracrine effect of post-MI-activatedevier B.V. All rights reserved.
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Adult murine cardiomyocytes developed signiﬁcant cellular hyper-
trophy when treated with ﬁbroblast-conditioned media, and when
co-cultured with cardiac ﬁbroblasts, they secreted high levels of
atrial natriuretic peptide [12]. Interestingly, conduction velocity
increased and APD70 reduced in these cultures with MI heart
myoﬁbroblasts compared with cultures with normal heart ﬁbro-
blasts [6,11]. Here, mathematical models could be used for
evaluating the myocyte–ﬁbroblast electrical interaction. Fibro-
blasts can inﬂuence conduction velocity by obstructing, creating
electrotonic load, and depolarizing myocytes. Since myoﬁbroblasts
have a less negative resting membrane potential, they can depo-
larize myocytes sufﬁciently to induce spontaneous pacemaking
when the myoﬁbroblast population exceeds 15% in co-cultures
[13]. Fibroblasts can couple to cardiomyocytes and substantially
affect their cellular electrical properties, including conduction,
resting potential, repolarization, and excitability. Such a myoﬁbro-
blast–myocyte coupling can trigger an arrhythmia such as EAD,
and these mechanisms may contribute to the proarrhythmic risk
in ﬁbrotic hearts via spontaneous impulse formation and rotor-
driven re-entry [14]. The increase in the resting membrane
potential of cardiomyocytes to more depolarized ﬁbroblasts by
coupling can result in an increase of conduction velocity even at
low ﬁbroblast concentrations [6]. Similar to a low ﬁbroblast
number, even weak electrical coupling (gap junction connectivity)
between myocytes and ﬁbroblasts can slightly increase the resting
membrane potential and conduction velocity of cardiomyocytes.
At intermediate coupling levels, ﬁbroblasts act as a current
capacitor, resulting in slow conduction velocity and decreased
maximum upstroke velocity with a decrease in sodium channel
activation [6].
Cardiac ﬁbroblasts express various ion channels, in particular
voltage-gated K+ channels and nonselective cation channels of the
transient receptor potential (TRP) family [15]. Both K+ and TRP
channels are important determinants of ﬁbroblast function, with
TRP channels acting as Ca2+ entry pathways that stimulate
ﬁbroblast differentiation into secretory myoﬁbroblast phenotypes
that produce ECM proteins. A study investigated the activity of
voltage-gated sodium channels in human atrial ﬁbroblasts and
myoﬁbroblasts [16] and found that the TRP melastatin-related 7
(TRPM7) channel, a Ca2+/Mg2+-permeable channel, is strongly
expressed in human atrial ﬁbroblasts and likely plays an essential
role in TGF-β-elicited ﬁbrogenesis in human AF [17]. Recently,
Harada et al. [18] showed that the Ca2+-permeable TRP canonical-
3 (TRPC3) channels regulate cardiac ﬁbroblast proliferation and
differentiation, perhaps by controlling the Ca2+ inﬂux that
activates extracellular signal-regulated kinase signaling. They
showed that TRPC3 expression was upregulated in atria of AF
patients, goats with electrically maintained AF, and dogs with
tachypacing-induced heart failure. Interestingly, the expression
and function of TRPC3 channels disappeared after differentiation
of ﬁbroblasts to myoﬁbroblasts under culture conditions, which
suggests that TRPC3 controls proliferation and differentiation of
ﬁbroblasts but is downregulated in the end-cell myoﬁbroblast.
This negative feedback system may prevent excessive ECM remo-
deling. In contrast, TRPM7 expression remained high in myoﬁbro-
blasts, implicating that TRPM7 is likely the dominant TRP channel
in differentiated myoﬁbroblasts [17].
TRPC3 channels act as a platform for protein kinase C asso-
ciated with ERK-1/2 activation, which contributes to ﬁbroblast
function. Because angiotensin II increases the cellular production
of diacylglycerol, which activates TRPC3 channels, angiotensin-
induced increases in intracellular Ca2+ and protein kinase C
activation synergistically contribute to ﬁbroblast proliferation via
the TRPC3 channel. Harada et al. [18] showed that a selective
TPRC3 channel blocker, pyrazole-3, suppressed angiotensinII-induced Ca2+ inﬂux, proliferation, and α-SMA protein expression
in ﬁbroblasts in addition to extracellular signal-regulated kinase
phosphorylation and ECM gene expression. Knocking down TRPC3
by small hairpin RNA decreased canine atrial ﬁbroblast prolifera-
tion. Harada et al. [18] also showed that microRNA-26 was down-
regulated in canine AF atria, and experimental microRNA-26
knockdown reproduced AF-induced TRPC3 upregulation and ﬁbro-
blast activation. MicroRNA-26 has nuclear factor of activated T cells
(NFAT) binding sites in the 5′ promoter region, and microRNA-26
transcription was negatively regulated by NFAT. Because NFAT
activation is increased in AF ﬁbroblasts, AF increases TRPC3
channel expression by causing NFAT-mediated downregulation of
microRNA-26 and causes TRPC3-dependent enhancement of ﬁbro-
blast proliferation and differentiation. In vivo, pyrazole-3 sup-
pressed AF while decreasing ﬁbroblast proliferation and ECM gene
expression. Harada et al. [18] introduces the possibility of a novel
potential therapeutic target that prevents ﬁbroblast activation for
the treatment of AF. The authors importantly showed that TRPC3
plays an important role in AF by promoting ﬁbroblast pathophy-
siology as well as the mechanism of TRPC upregulation in AF via
microRNA-26. The present ﬁndings point to TRPC3 as a candidate
target for AF prevention.
However, arguably, the main limitation of this study is that
properties of ﬁbroblasts were probably affected by cell isolation
and culture conditions. Any extrapolation of these results to
human disease should be made cautiously. Further, the discre-
pancy between atrial ﬁbroblast density/signs of ﬁbroblast activa-
tion and ﬁbrous tissue content in AF dogs (7 days) showed that
longer intervals (43 months) are necessary for ﬁbrosis develop-
ment. However, myoﬁbroblast–myocyte coupling as an arrhythmia
trigger does not require enhanced ﬁbrous tissue content; there-
fore, ﬁbroblast proliferation and differentiation can promote AF.
Fibrosis, inﬂammation, and oxidative stress appear strongly
interconnected in the pathogenesis of remodeling-induced
abnormalities. Moreover, insights into the ECM network strongly
suggested an active cross-talk within the cardiac microenviron-
ment, which should be further investigated as a promising “anti-
remodeling” approach. In addition, the excess ECM proteins
produced by ﬁbroblasts can interrupt cardiomyocyte-bundle con-
tinuity, leading to local conduction disturbances and re-entrant
arrhythmias, resulting in “electric-structural remodeling.” There-
fore, a better understanding of the electrical properties of ﬁbro-
blasts could lead to an improved comprehension of AF
pathophysiology, and pharmacological modulation of ionic targets
associated with atrial ﬁbrosis would be an area of interest in
preventive strategy in AF.Conﬂict of interest
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